Quest Diagnostics, Inc. (DGX)
259.60
-0.05
(-0.02%)
USD |
NYSE |
Nov 13, 16:00
259.58
-0.02
(-0.01%)
After-Hours: 19:59
Quest Diagnostics EPS Diluted (Quarterly) : 2.768 for Sept. 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 2.768 |
| June 30, 2026 | 2.848 |
| March 31, 2026 | 2.241 |
| December 31, 2025 | 2.188 |
| September 30, 2025 | 2.150 |
| June 30, 2025 | 2.487 |
| March 31, 2025 | 1.938 |
| December 31, 2024 | 1.947 |
| September 30, 2024 | 1.991 |
| June 30, 2024 | 2.036 |
| March 31, 2024 | 1.723 |
| December 31, 2023 | 1.699 |
| September 30, 2023 | 1.956 |
| June 30, 2023 | 2.053 |
| March 31, 2023 | 1.779 |
| December 31, 2022 | 0.8783 |
| September 30, 2022 | 2.152 |
| June 30, 2022 | 1.958 |
| March 31, 2022 | 2.926 |
| December 31, 2021 | 3.112 |
| September 30, 2021 | 4.024 |
| June 30, 2021 | 4.945 |
| March 31, 2021 | 3.467 |
| December 31, 2020 | 4.204 |
| September 30, 2020 | 4.131 |
| Date | Value |
|---|---|
| June 30, 2020 | 1.353 |
| March 31, 2020 | 0.7333 |
| December 31, 2019 | 1.853 |
| September 30, 2019 | 1.562 |
| June 30, 2019 | 1.662 |
| March 31, 2019 | 1.198 |
| December 31, 2018 | 0.92 |
| September 30, 2018 | 1.53 |
| June 30, 2018 | 1.576 |
| March 31, 2018 | 1.27 |
| December 31, 2017 | 1.82 |
| September 30, 2017 | 1.143 |
| June 30, 2017 | 1.379 |
| March 31, 2017 | 1.16 |
| December 31, 2016 | 1.099 |
| September 30, 2016 | 1.34 |
| June 30, 2016 | 1.37 |
| March 31, 2016 | 0.7153 |
| December 31, 2015 | 1.306 |
| September 30, 2015 | 2.345 |
| June 30, 2015 | 0.81 |
| March 31, 2015 | 0.42 |
| December 31, 2014 | 1.301 |
| September 30, 2014 | 0.88 |
| June 30, 2014 | 0.92 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Labcorp Holdings, Inc. | 3.221 |
| Fulgent Genetics, Inc. | -0.4754 |
| OPKO Health, Inc. | -0.0717 |
| Psychemedics Corp. | -- |
| NeoGenomics, Inc. | -0.0587 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 324.00M |
| Revenue (Quarterly) | 3.097B |
| Total Expenses (Quarterly) | 2.787B |
| Enterprise Value | 34.44B |
| Gross Profit Margin (Quarterly) | 32.48% |
| Profit Margin (Quarterly) | 10.46% |
| Earnings Yield | 3.87% |
| Operating Earnings Yield | 6.01% |
| Normalized Earnings Yield | 4.242 |